| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 73 | 2024 | 236 | 14.360 |
Why?
|
| Melatonin | 49 | 2024 | 82 | 9.750 |
Why?
|
| Retina | 47 | 2024 | 289 | 8.060 |
Why?
|
| Receptor, Melatonin, MT1 | 18 | 2024 | 19 | 6.460 |
Why?
|
| Retinal Pigment Epithelium | 10 | 2022 | 31 | 4.500 |
Why?
|
| Receptor, Melatonin, MT2 | 9 | 2024 | 10 | 3.940 |
Why?
|
| Photoreceptor Cells, Vertebrate | 14 | 2019 | 33 | 3.850 |
Why?
|
| Gene Expression Regulation | 27 | 2024 | 1070 | 3.120 |
Why?
|
| Photoreceptor Cells | 15 | 2022 | 39 | 2.890 |
Why?
|
| Signal Transduction | 19 | 2024 | 2157 | 2.750 |
Why?
|
| Retinal Cone Photoreceptor Cells | 8 | 2024 | 31 | 2.560 |
Why?
|
| Animals | 105 | 2024 | 16992 | 2.310 |
Why?
|
| Receptors, Melatonin | 10 | 2024 | 11 | 2.250 |
Why?
|
| Period Circadian Proteins | 15 | 2022 | 37 | 2.200 |
Why?
|
| Mice | 47 | 2024 | 6644 | 2.130 |
Why?
|
| Aging | 8 | 2022 | 783 | 2.050 |
Why?
|
| Retinal Degeneration | 10 | 2020 | 15 | 2.010 |
Why?
|
| Pineal Gland | 16 | 2016 | 31 | 1.920 |
Why?
|
| Light | 19 | 2022 | 185 | 1.790 |
Why?
|
| Mice, Knockout | 20 | 2024 | 1035 | 1.540 |
Why?
|
| Lipid Metabolism | 3 | 2024 | 148 | 1.540 |
Why?
|
| Liver | 4 | 2024 | 511 | 1.520 |
Why?
|
| Dopamine | 11 | 2018 | 275 | 1.340 |
Why?
|
| Eye Proteins | 4 | 2020 | 63 | 1.340 |
Why?
|
| Phagocytosis | 3 | 2022 | 86 | 1.320 |
Why?
|
| Biological Clocks | 13 | 2008 | 52 | 1.320 |
Why?
|
| Mammals | 7 | 2024 | 112 | 1.310 |
Why?
|
| Macular Degeneration | 2 | 2022 | 31 | 1.170 |
Why?
|
| Receptors, Dopamine D2 | 3 | 2020 | 83 | 1.170 |
Why?
|
| Leptin | 2 | 2020 | 118 | 1.160 |
Why?
|
| Suprachiasmatic Nucleus | 14 | 2018 | 43 | 1.160 |
Why?
|
| RNA, Messenger | 24 | 2017 | 1271 | 1.080 |
Why?
|
| Luciferases | 4 | 2022 | 71 | 1.030 |
Why?
|
| Arylamine N-Acetyltransferase | 10 | 2015 | 26 | 1.030 |
Why?
|
| Protein Multimerization | 2 | 2019 | 115 | 0.960 |
Why?
|
| Chronobiology Disorders | 2 | 2020 | 4 | 0.930 |
Why?
|
| Electroretinography | 8 | 2022 | 21 | 0.910 |
Why?
|
| Retinal Ganglion Cells | 4 | 2015 | 49 | 0.880 |
Why?
|
| CLOCK Proteins | 10 | 2019 | 23 | 0.880 |
Why?
|
| Mice, Inbred C57BL | 17 | 2024 | 1869 | 0.800 |
Why?
|
| Intraocular Pressure | 3 | 2013 | 132 | 0.780 |
Why?
|
| Proteome | 1 | 2024 | 152 | 0.780 |
Why?
|
| Rod Opsins | 7 | 2009 | 16 | 0.780 |
Why?
|
| Insulin Resistance | 2 | 2018 | 201 | 0.740 |
Why?
|
| Trans-Activators | 7 | 2008 | 192 | 0.740 |
Why?
|
| Lenses | 1 | 2022 | 4 | 0.740 |
Why?
|
| Glutathione Peroxidase | 1 | 2022 | 112 | 0.730 |
Why?
|
| Lens, Crystalline | 1 | 2022 | 39 | 0.710 |
Why?
|
| Ocular Physiological Phenomena | 3 | 2018 | 9 | 0.680 |
Why?
|
| Blood Glucose | 2 | 2016 | 389 | 0.680 |
Why?
|
| Serotonin | 6 | 2014 | 123 | 0.680 |
Why?
|
| Homozygote | 1 | 2020 | 77 | 0.660 |
Why?
|
| Male | 39 | 2024 | 23409 | 0.660 |
Why?
|
| Ghrelin | 1 | 2020 | 17 | 0.660 |
Why?
|
| Nuclear Proteins | 12 | 2008 | 333 | 0.640 |
Why?
|
| Dyslipidemias | 1 | 2020 | 48 | 0.630 |
Why?
|
| Rats | 22 | 2017 | 3735 | 0.630 |
Why?
|
| ARNTL Transcription Factors | 6 | 2022 | 13 | 0.620 |
Why?
|
| Dark Adaptation | 3 | 2018 | 17 | 0.620 |
Why?
|
| Cornea | 2 | 2018 | 70 | 0.580 |
Why?
|
| Adaptation, Ocular | 1 | 2018 | 12 | 0.580 |
Why?
|
| Insulin | 1 | 2020 | 258 | 0.570 |
Why?
|
| Motor Activity | 6 | 2010 | 437 | 0.570 |
Why?
|
| Fas Ligand Protein | 1 | 2017 | 17 | 0.550 |
Why?
|
| Isoenzymes | 1 | 2018 | 168 | 0.550 |
Why?
|
| Arylalkylamine N-Acetyltransferase | 3 | 2006 | 5 | 0.540 |
Why?
|
| Gene Expression | 3 | 2018 | 701 | 0.540 |
Why?
|
| Protein Kinase C | 1 | 2018 | 124 | 0.530 |
Why?
|
| Photic Stimulation | 5 | 2016 | 125 | 0.520 |
Why?
|
| Caspase 3 | 1 | 2017 | 227 | 0.510 |
Why?
|
| Hydrogen Peroxide | 1 | 2017 | 190 | 0.510 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 863 | 0.500 |
Why?
|
| Oxidative Stress | 1 | 2022 | 1003 | 0.490 |
Why?
|
| Cells, Cultured | 10 | 2017 | 1621 | 0.490 |
Why?
|
| Obesity | 2 | 2021 | 1151 | 0.470 |
Why?
|
| Choroid | 2 | 2017 | 11 | 0.470 |
Why?
|
| Transcription Factors | 12 | 2015 | 735 | 0.460 |
Why?
|
| Cell Cycle Proteins | 9 | 2008 | 241 | 0.450 |
Why?
|
| Mice, Inbred C3H | 8 | 2017 | 80 | 0.440 |
Why?
|
| Vision, Ocular | 2 | 2018 | 43 | 0.440 |
Why?
|
| Immunohistochemistry | 5 | 2017 | 934 | 0.440 |
Why?
|
| Retinal Rod Photoreceptor Cells | 2 | 2013 | 17 | 0.430 |
Why?
|
| Cyclic GMP | 2 | 2012 | 53 | 0.430 |
Why?
|
| Antioxidants | 1 | 2017 | 443 | 0.420 |
Why?
|
| Sleep | 2 | 2014 | 185 | 0.410 |
Why?
|
| Cyclic AMP | 4 | 2019 | 127 | 0.410 |
Why?
|
| Sleep Deprivation | 2 | 2011 | 28 | 0.400 |
Why?
|
| Neuroprotective Agents | 3 | 2014 | 269 | 0.400 |
Why?
|
| Humans | 26 | 2022 | 43102 | 0.400 |
Why?
|
| Nitroprusside | 1 | 2012 | 14 | 0.390 |
Why?
|
| Ciliary Body | 1 | 2012 | 14 | 0.380 |
Why?
|
| Cell Line | 4 | 2022 | 1410 | 0.380 |
Why?
|
| Excitatory Amino Acid Agonists | 5 | 2006 | 43 | 0.380 |
Why?
|
| Iguanas | 3 | 1998 | 3 | 0.380 |
Why?
|
| Neurogenesis | 2 | 2012 | 63 | 0.380 |
Why?
|
| Rats, Wistar | 8 | 2007 | 283 | 0.370 |
Why?
|
| Cell Survival | 4 | 2018 | 945 | 0.370 |
Why?
|
| Glaucoma | 1 | 2013 | 100 | 0.360 |
Why?
|
| Kainic Acid | 3 | 2006 | 48 | 0.360 |
Why?
|
| Factor VII | 2 | 2010 | 3 | 0.340 |
Why?
|
| Disease Models, Animal | 6 | 2017 | 1596 | 0.340 |
Why?
|
| Models, Biological | 4 | 2020 | 712 | 0.340 |
Why?
|
| Luminescent Proteins | 1 | 2010 | 68 | 0.330 |
Why?
|
| Cell Death | 1 | 2011 | 278 | 0.320 |
Why?
|
| Brain | 4 | 2015 | 1472 | 0.310 |
Why?
|
| Models, Animal | 2 | 2020 | 151 | 0.310 |
Why?
|
| Nitric Oxide | 1 | 2012 | 386 | 0.310 |
Why?
|
| Mutation | 6 | 2015 | 1177 | 0.300 |
Why?
|
| Up-Regulation | 2 | 2020 | 536 | 0.300 |
Why?
|
| Norepinephrine | 3 | 2003 | 97 | 0.290 |
Why?
|
| Glucose | 1 | 2010 | 244 | 0.280 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2010 | 652 | 0.280 |
Why?
|
| Phosphorylation | 3 | 2020 | 986 | 0.270 |
Why?
|
| Mice, Transgenic | 2 | 2022 | 665 | 0.270 |
Why?
|
| Light Signal Transduction | 1 | 2007 | 6 | 0.260 |
Why?
|
| Rodentia | 1 | 2007 | 47 | 0.250 |
Why?
|
| Temperature | 5 | 2001 | 313 | 0.250 |
Why?
|
| Body Temperature Regulation | 2 | 1996 | 8 | 0.240 |
Why?
|
| Darkness | 5 | 2009 | 28 | 0.240 |
Why?
|
| Analysis of Variance | 3 | 2018 | 575 | 0.240 |
Why?
|
| Blotting, Western | 3 | 2016 | 883 | 0.230 |
Why?
|
| Photoperiod | 4 | 2015 | 27 | 0.230 |
Why?
|
| Space Flight | 1 | 2005 | 17 | 0.220 |
Why?
|
| Vertebrates | 4 | 2006 | 34 | 0.220 |
Why?
|
| In Situ Hybridization | 7 | 2006 | 138 | 0.220 |
Why?
|
| Jet Lag Syndrome | 1 | 2024 | 8 | 0.220 |
Why?
|
| Cricetinae | 9 | 2006 | 241 | 0.220 |
Why?
|
| Receptor, trkB | 3 | 2014 | 20 | 0.210 |
Why?
|
| Behavior, Animal | 3 | 2004 | 373 | 0.210 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2003 | 32 | 0.210 |
Why?
|
| Gene Expression Profiling | 2 | 2007 | 704 | 0.200 |
Why?
|
| Hippocampus | 3 | 2019 | 594 | 0.200 |
Why?
|
| Phagocytes | 1 | 2022 | 7 | 0.190 |
Why?
|
| Receptors, Dopamine D4 | 3 | 2017 | 16 | 0.190 |
Why?
|
| Eyeglasses | 1 | 2022 | 22 | 0.180 |
Why?
|
| Peptide Hydrolases | 1 | 2001 | 44 | 0.180 |
Why?
|
| Lighting | 2 | 2004 | 12 | 0.180 |
Why?
|
| Multienzyme Complexes | 1 | 2001 | 69 | 0.180 |
Why?
|
| Cysteine Endopeptidases | 1 | 2001 | 64 | 0.180 |
Why?
|
| Acetylcysteine | 1 | 2001 | 57 | 0.170 |
Why?
|
| Reptiles | 1 | 2001 | 4 | 0.170 |
Why?
|
| Nerve Tissue Proteins | 2 | 2018 | 386 | 0.170 |
Why?
|
| Resistin | 1 | 2020 | 4 | 0.170 |
Why?
|
| Glucagon | 1 | 2020 | 7 | 0.170 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 3 | 2011 | 27 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2017 | 1124 | 0.160 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2021 | 70 | 0.160 |
Why?
|
| Mesocricetus | 7 | 2006 | 56 | 0.160 |
Why?
|
| Culture Techniques | 4 | 2004 | 25 | 0.160 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2020 | 21 | 0.160 |
Why?
|
| Tomography, Optical Coherence | 1 | 2020 | 38 | 0.160 |
Why?
|
| Phagosomes | 1 | 2020 | 33 | 0.160 |
Why?
|
| Integrins | 1 | 2020 | 54 | 0.160 |
Why?
|
| Female | 10 | 2022 | 24698 | 0.160 |
Why?
|
| Lizards | 2 | 2001 | 27 | 0.160 |
Why?
|
| Time Factors | 5 | 2010 | 1857 | 0.160 |
Why?
|
| Cardiotonic Agents | 1 | 2000 | 40 | 0.160 |
Why?
|
| Adiposity | 1 | 2021 | 157 | 0.160 |
Why?
|
| Eye | 3 | 2006 | 77 | 0.150 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 98 | 0.150 |
Why?
|
| Body Temperature | 2 | 1998 | 35 | 0.150 |
Why?
|
| Gene Deletion | 1 | 2019 | 168 | 0.140 |
Why?
|
| Luminescent Measurements | 1 | 2018 | 26 | 0.140 |
Why?
|
| Aging, Premature | 1 | 2018 | 6 | 0.140 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2017 | 7 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2018 | 760 | 0.140 |
Why?
|
| Oxidants | 1 | 2017 | 42 | 0.140 |
Why?
|
| Neuronal Plasticity | 1 | 2019 | 126 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 299 | 0.130 |
Why?
|
| Gene Knock-In Techniques | 1 | 2017 | 18 | 0.130 |
Why?
|
| Learning | 1 | 2019 | 161 | 0.130 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 224 | 0.130 |
Why?
|
| Body Mass Index | 1 | 2021 | 925 | 0.130 |
Why?
|
| tau Proteins | 1 | 1998 | 186 | 0.130 |
Why?
|
| Periodicity | 2 | 2008 | 34 | 0.120 |
Why?
|
| Skin Physiological Phenomena | 1 | 1996 | 10 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2017 | 1766 | 0.120 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2015 | 3 | 0.120 |
Why?
|
| Murinae | 1 | 2015 | 4 | 0.120 |
Why?
|
| Fatty Acids | 1 | 2016 | 134 | 0.120 |
Why?
|
| Luminescent Agents | 1 | 2015 | 4 | 0.120 |
Why?
|
| Dopamine Agonists | 3 | 2008 | 34 | 0.120 |
Why?
|
| Rats, Inbred F344 | 2 | 2006 | 258 | 0.110 |
Why?
|
| Organ Culture Techniques | 2 | 2007 | 101 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2007 | 310 | 0.110 |
Why?
|
| Gene Knockout Techniques | 1 | 2014 | 53 | 0.110 |
Why?
|
| Homeostasis | 1 | 2016 | 192 | 0.110 |
Why?
|
| Adipose Tissue | 1 | 2016 | 182 | 0.110 |
Why?
|
| Neuropeptide Y | 2 | 2006 | 25 | 0.110 |
Why?
|
| Chickens | 2 | 2006 | 161 | 0.110 |
Why?
|
| Seasons | 2 | 2007 | 139 | 0.100 |
Why?
|
| Type C Phospholipases | 1 | 2013 | 23 | 0.100 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 316 | 0.100 |
Why?
|
| Tryptamines | 1 | 2012 | 7 | 0.100 |
Why?
|
| Antidepressive Agents | 2 | 2011 | 65 | 0.100 |
Why?
|
| Isoindoles | 1 | 2012 | 16 | 0.100 |
Why?
|
| Aqueous Humor | 1 | 2012 | 18 | 0.100 |
Why?
|
| Neurons | 2 | 2015 | 1263 | 0.090 |
Why?
|
| Colorimetry | 1 | 2012 | 53 | 0.090 |
Why?
|
| Immunoassay | 1 | 2012 | 74 | 0.090 |
Why?
|
| Night Blindness | 1 | 2012 | 1 | 0.090 |
Why?
|
| Retinal Bipolar Cells | 1 | 2012 | 3 | 0.090 |
Why?
|
| Transcription, Genetic | 3 | 2008 | 592 | 0.090 |
Why?
|
| Injections | 2 | 2006 | 42 | 0.090 |
Why?
|
| Myopia | 1 | 2012 | 27 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 93 | 0.090 |
Why?
|
| Cell Count | 1 | 2011 | 145 | 0.080 |
Why?
|
| Animals, Newborn | 2 | 2003 | 352 | 0.080 |
Why?
|
| Drug Interactions | 3 | 2005 | 150 | 0.080 |
Why?
|
| Factor VIIa | 1 | 2010 | 2 | 0.080 |
Why?
|
| Thromboplastin | 1 | 2010 | 6 | 0.080 |
Why?
|
| Thrombin | 1 | 2010 | 28 | 0.080 |
Why?
|
| Adaptation, Biological | 1 | 2009 | 29 | 0.080 |
Why?
|
| Radioimmunoassay | 4 | 2006 | 70 | 0.080 |
Why?
|
| Zebrafish | 2 | 2012 | 146 | 0.080 |
Why?
|
| Xenopus laevis | 2 | 2006 | 73 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2012 | 434 | 0.080 |
Why?
|
| Weight Loss | 1 | 2010 | 137 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 465 | 0.070 |
Why?
|
| Quinoxalines | 2 | 2005 | 16 | 0.070 |
Why?
|
| GTP-Binding Protein Regulators | 1 | 2008 | 3 | 0.070 |
Why?
|
| Feedback, Physiological | 1 | 2008 | 32 | 0.070 |
Why?
|
| Aged | 1 | 2021 | 8214 | 0.070 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2005 | 92 | 0.070 |
Why?
|
| Animals, Congenic | 1 | 2007 | 11 | 0.070 |
Why?
|
| Eye Enucleation | 1 | 2007 | 3 | 0.070 |
Why?
|
| Rats, Mutant Strains | 1 | 2007 | 7 | 0.070 |
Why?
|
| Denervation | 1 | 2007 | 27 | 0.070 |
Why?
|
| Animals, Genetically Modified | 1 | 2007 | 100 | 0.070 |
Why?
|
| N-Methylaspartate | 2 | 2004 | 59 | 0.060 |
Why?
|
| Visual Pathways | 1 | 2007 | 40 | 0.060 |
Why?
|
| Physical Conditioning, Animal | 1 | 2007 | 33 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2010 | 549 | 0.060 |
Why?
|
| Monitoring, Physiologic | 1 | 2007 | 39 | 0.060 |
Why?
|
| Transfection | 2 | 2006 | 532 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2008 | 206 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 125 | 0.060 |
Why?
|
| Nerve Degeneration | 1 | 2007 | 111 | 0.060 |
Why?
|
| Rhodopsin | 1 | 2006 | 25 | 0.060 |
Why?
|
| Coturnix | 1 | 2005 | 2 | 0.060 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 2005 | 10 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2004 | 166 | 0.060 |
Why?
|
| Quinpirole | 1 | 2005 | 18 | 0.060 |
Why?
|
| Middle Aged | 1 | 2021 | 12222 | 0.060 |
Why?
|
| Dopamine Antagonists | 2 | 2008 | 48 | 0.060 |
Why?
|
| Receptors, AMPA | 1 | 2005 | 58 | 0.060 |
Why?
|
| Organ Specificity | 2 | 2006 | 141 | 0.060 |
Why?
|
| Hypothalamus | 1 | 2006 | 120 | 0.060 |
Why?
|
| Time | 1 | 2005 | 15 | 0.060 |
Why?
|
| Software | 1 | 2007 | 236 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1455 | 0.060 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2004 | 3 | 0.050 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2004 | 29 | 0.050 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2004 | 17 | 0.050 |
Why?
|
| Nerve Growth Factors | 1 | 2004 | 34 | 0.050 |
Why?
|
| Adult | 1 | 2021 | 13872 | 0.050 |
Why?
|
| Tetrodotoxin | 1 | 2004 | 22 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2006 | 307 | 0.050 |
Why?
|
| Neurotransmitter Agents | 1 | 2004 | 69 | 0.050 |
Why?
|
| Neuropeptides | 1 | 2004 | 64 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 314 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2004 | 148 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 186 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 526 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 734 | 0.050 |
Why?
|
| DNA Primers | 1 | 2003 | 294 | 0.050 |
Why?
|
| Valine | 1 | 2003 | 29 | 0.050 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2003 | 81 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 257 | 0.050 |
Why?
|
| Depression | 1 | 2010 | 863 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2002 | 20 | 0.050 |
Why?
|
| Sympathomimetics | 1 | 2002 | 8 | 0.050 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2002 | 27 | 0.050 |
Why?
|
| Mice, Inbred Strains | 2 | 2001 | 114 | 0.050 |
Why?
|
| Lipoproteins | 1 | 2022 | 70 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2002 | 54 | 0.050 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2001 | 22 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2022 | 81 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2014 | 81 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 91 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2001 | 116 | 0.040 |
Why?
|
| Culture Media | 1 | 2000 | 96 | 0.040 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2000 | 13 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2001 | 132 | 0.040 |
Why?
|
| Lipids | 1 | 2022 | 256 | 0.040 |
Why?
|
| Receptors, Dopamine | 1 | 2000 | 30 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 196 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2001 | 456 | 0.040 |
Why?
|
| Fungi | 1 | 2000 | 106 | 0.040 |
Why?
|
| Oscillometry | 1 | 1998 | 9 | 0.040 |
Why?
|
| Animal Structures | 1 | 1998 | 22 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2006 | 1180 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2006 | 1542 | 0.030 |
Why?
|
| Locomotion | 1 | 1998 | 105 | 0.030 |
Why?
|
| Bacteria | 1 | 2000 | 293 | 0.030 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 2016 | 5 | 0.030 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2016 | 10 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2016 | 42 | 0.030 |
Why?
|
| Genes | 1 | 1996 | 56 | 0.030 |
Why?
|
| Parietal Lobe | 1 | 1996 | 10 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 256 | 0.030 |
Why?
|
| Telemetry | 1 | 1995 | 14 | 0.030 |
Why?
|
| Acetylserotonin O-Methyltransferase | 1 | 2015 | 2 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 95 | 0.030 |
Why?
|
| Diabetic Retinopathy | 1 | 2016 | 78 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2016 | 187 | 0.030 |
Why?
|
| Genotype | 1 | 1998 | 800 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 457 | 0.030 |
Why?
|
| Ligands | 1 | 2016 | 388 | 0.030 |
Why?
|
| Skin | 1 | 1996 | 187 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 143 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2014 | 83 | 0.030 |
Why?
|
| DNA | 1 | 2015 | 592 | 0.020 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2012 | 2 | 0.020 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2012 | 16 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2014 | 173 | 0.020 |
Why?
|
| Pedigree | 1 | 2012 | 94 | 0.020 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2012 | 26 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 110 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2012 | 199 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 189 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2011 | 139 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 224 | 0.020 |
Why?
|
| Cryptochromes | 1 | 2008 | 3 | 0.020 |
Why?
|
| E-Box Elements | 1 | 2008 | 2 | 0.020 |
Why?
|
| Flavoproteins | 1 | 2008 | 16 | 0.020 |
Why?
|
| Alaska | 1 | 2007 | 62 | 0.020 |
Why?
|
| New York | 1 | 2007 | 93 | 0.020 |
Why?
|
| Dogs | 1 | 2007 | 204 | 0.020 |
Why?
|
| 5-Hydroxytryptophan | 1 | 2005 | 4 | 0.010 |
Why?
|
| Tissue Culture Techniques | 1 | 2005 | 36 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2006 | 272 | 0.010 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2005 | 135 | 0.010 |
Why?
|
| Anesthetics, Local | 1 | 2004 | 20 | 0.010 |
Why?
|
| Autoradiography | 1 | 2003 | 37 | 0.010 |
Why?
|
| Microinjections | 1 | 2003 | 50 | 0.010 |
Why?
|
| Phylogeny | 1 | 2006 | 769 | 0.010 |
Why?
|
| Receptors, Neuropeptide Y | 1 | 2001 | 7 | 0.010 |
Why?
|
| Genes, Intracisternal A-Particle | 1 | 2001 | 2 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 2001 | 21 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2001 | 88 | 0.010 |
Why?
|
| Cattle | 1 | 2001 | 498 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2001 | 307 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2001 | 694 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2001 | 188 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 2676 | 0.010 |
Why?
|
| Proteins | 1 | 2001 | 382 | 0.010 |
Why?
|